Ces radiol. 2012, 66(1):49-55

Method of radioguided sentinel lymph node biopsy in breast cancer patient - status in the Czech Republic in 2010Original article

Milan Šimánek1, Pavel Koranda2
1 Oddělení nukleární medicíny Nemocnice Pelhřimov p. o.
2 Klinika nukleární medicíny FN a LF UP, Olomouc

Aim: Evaluation of currently used lymphoscintigraphic procedures for sentinel lymph node biopsy (SLNB) in Nuclear Medicine Departments in the Czech Republic (CR) with surgical solving of different clinical findings and comparison with the recently published papers.

Methods: Questionnaire completed at Nuclear Medicine Departments.

Results: There are stated essential variants of used parameters in 29 departments in the summary tables. Indication - breast carcinoma T1 to T2, sporadically T3. In case of DCIS patients the SLNB is performed in 67% and after neoadjuvant chemotherapy in 57%. Small and large particles of the similar activity are injected in the same percentage. Peritumoral injection is a bit preffered in comparison to superficial injections. The SLNB is indicated in case of multicentric/multifocal carcinoma in 55% and the application site is in 60% of patients periareolar. Lymphoscintigraphy is performed in all departments. Surgery is performed on the same day in 50%, there is always transcutaneus activity counted. Only a third of the departments use blue dye injections. The number of removed nodes is on the average 1.7. One half of surgeons wait for histological results of sentinel lymph node (SLN). Pathologists mostly use immunohistochemistry. Axillary lymph node dissection is performed in 80% in the presence of SLN micrometastases and in 50% in case of isolated tumor cells every time. Extraaxillary SLNs are removed with limitations. Success of SLNB is recorded in 90%.

Conclusion: The essential differences in the methods of SLNB in different departments in the CR correspond to commonly accepted modifications.

Keywords: breast cancer, scintigraphy, sentinel lymph node biopsy

Accepted: January 15, 2012; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimánek M, Koranda P. Method of radioguided sentinel lymph node biopsy in breast cancer patient - status in the Czech Republic in 2010. Ces radiol. 2012;66(1):49-55.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. Surg Oncol 2010; 102(2): 111-118. Go to original source... Go to PubMed...
    2. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11(10): 927-933. Go to original source... Go to PubMed...
    3. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid AD in breast cancer with clinically negative lymph nodes. Lancet 2007; 349: 1864-1867. Go to original source... Go to PubMed...
    4. Daňková S, Holub J, Hrkal J, et al. Vývoj zdravotnictví České republiky po roce 1989. Praha: ÚZIS ČR 2010.
    5. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (or = 5 cm) invasive breast cancer. Ann Surg Oncol 2001; 8(9): 688-692. Go to original source...
    6. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002; 95(5): 982-988. Go to original source... Go to PubMed...
    7. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23(30): 7703-7720. Go to original source... Go to PubMed...
    8. Schnitt SJ, Silen W, Sadowsky NL, et al. Ductal carcinoma in situ. N Engl Med 1988; 318: 898-902. Go to original source... Go to PubMed...
    9. Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in DCIS patients. Ann Surg Oncol 2000; 7: 15-20. Go to original source... Go to PubMed...
    10. Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2005; 23(12): 2694-2702. Go to original source... Go to PubMed...
    11. Newman EA, Sabel MS, Nees AV, et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 2007; 14(10): 2946-2952. Go to original source... Go to PubMed...
    12. Bedrosian I, Reynolds C, Mick R, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88(11): 2540-2545. Go to original source...
    13. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18(20): 3480-3486. Go to original source... Go to PubMed...
    14. Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002; 9(3): 235-242. Go to original source... Go to PubMed...
    15. Buscombe J, Paganelli G, Burak ZE, et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34: 2154-2159. Go to original source... Go to PubMed...
    16. Shimazu K, Tamaki Y, Taguchi T, et al. Lymphoscintigraphic visualisation of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 2003; 237(3): 390-398. Go to original source... Go to PubMed...
    17. van der Ent FW, Kengen RA, van der Pol HA, et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234(1): 79-84. Go to original source... Go to PubMed...
    18. Heuts EM, van der Ent FW, von Meyenfeldt MF, et al. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol 2009; 35(3): 252-257. Go to original source... Go to PubMed...
    19. Shahar KH, Buchholz TA, Delpassand E, et al. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 2005; 103(7): 1323-1329. Go to original source... Go to PubMed...
    20. Chagpar A, Martin RC 3rd, Chao C, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 2004; 139(6): 614-618; discussion 618-620. Go to original source... Go to PubMed...
    21. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229(6): 860-864. Go to original source... Go to PubMed...
    22. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 2000; 232(1): 81-89. Go to original source... Go to PubMed...
    23. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005; 189(2): 36-39. Go to original source... Go to PubMed...
    24. Bleicher RJ, Kloth DD, Robinson D, et al. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 2009; 99(6): 356-360. Go to original source... Go to PubMed...
    25. Liu LC, Lang JE, Jenkins T, et al. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? J Am Coll Surg 2008; 207(6): 853-858. Go to original source... Go to PubMed...
    26. Chung A, Yu J, Stempel M, Patil S, et al. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients? Ann Surg Oncol 2008; 15(10): 2728-2733. Go to original source... Go to PubMed...
    27. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8(10): 881-888. Go to original source... Go to PubMed...
    28. Vanderveen KA, Ramsamooj R, Bold RJ. A prospective, blinded trial of touch prep analysis versus frozen section for intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol 2008; 15(7): 2006-2011. Go to original source... Go to PubMed...
    29. Olson JA Jr, McCall LM, Beitsch P, et al. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 2008; 26(21): 3530-3535. Go to original source... Go to PubMed...
    30. Gobardhan PD, Elias SG, Madsen EV, et al. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol 2009; 20(1): 41-48. Go to original source... Go to PubMed...
    31. Reed J, Rosman M, Verbanac KM, et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009; 208(3): 333-340. Go to original source... Go to PubMed...
    32. Pugliese MS, Stempel MM, Cody HS 3rd, et al. Surgical management of the axilla: do intramammary nodes matter? Am J Surg 2009; 198(4): 532-537. Go to original source... Go to PubMed...
    33. Morrow M, Foster RS Jr. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg 1981; 116(6): 748-751. Go to original source... Go to PubMed...
    34. Chen RC, Lin NU, Golshan M, et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management - a systematic review. J Clin Oncol 2008; 26(30): 4981-4989. Go to original source... Go to PubMed...
    35. Mansel RE, Goyal A, Newcombe RG. Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 2004; 5(4): 279-284. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content